News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
102,018 Results
Type
Article (6275)
Company Profile (20)
Press Release (95723)
Multimedia
Podcasts (1)
Webinars (1)
Section
Business (30744)
Career Advice (199)
Deals (4752)
Drug Delivery (5)
Drug Development (8916)
Employer Resources (11)
FDA (2883)
Job Trends (2929)
News (49600)
Policy (5450)
Tag
2024 BioCapital Digital (1)
2024 BioMidwest Digital (2)
2024 Bio NC Digital (3)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (1)
Academia (662)
Academic (1)
Allergies (14)
Alliances (9933)
ALS (6)
Alzheimer's disease (185)
Antibody-drug conjugate (ADC) (13)
Approvals (2923)
Artificial intelligence (33)
Automation (8)
Bankruptcy (26)
Best Places to Work (2268)
BIOSECURE Act (1)
Biosimilars (5)
Biotechnology (14)
Bladder cancer (10)
Brain cancer (4)
Breast cancer (47)
Cancer (342)
Cardiovascular disease (20)
Career advice (183)
Career pathing (1)
CAR-T (21)
Cell therapy (47)
Cervical cancer (9)
Clinical research (6915)
Collaboration (144)
Compensation (2)
Complete response letters (3)
COVID-19 (549)
CRISPR (5)
C-suite (21)
Cystic fibrosis (7)
Data (286)
Depression (1)
Diabetes (22)
Diagnostics (3156)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (20)
Drug pricing (2)
Drug shortages (1)
Duchenne muscular dystrophy (8)
Earnings (8839)
Employer branding (3)
Employer resources (9)
Events (10199)
Executive appointments (100)
FDA (3026)
Featured Employer (4)
Frontotemporal dementia (1)
Funding (75)
Gene editing (7)
Generative AI (3)
Gene therapy (33)
GLP-1 (102)
Government (897)
Grass and pollen (3)
Guidances (5)
Healthcare (2250)
Immunology and inflammation (3)
Indications (3)
Infectious disease (577)
Inflammatory bowel disease (7)
Influenza (12)
Intellectual property (11)
Interviews (24)
IPO (1410)
Job creations (773)
Job search strategy (174)
Kidney cancer (1)
Labor market (2)
Layoffs (31)
Leadership (1)
Legal (1112)
Liver cancer (8)
Lung cancer (60)
Lymphoma (26)
Machine learning (1)
Management (3)
Manufacturing (48)
MASH (3)
Medical device (1360)
Medtech (1360)
Mergers & acquisitions (3411)
Metabolic disorders (42)
Multiple sclerosis (3)
NASH (1)
Neurodegenerative disease (11)
Neuropsychiatric disorders (1)
Neuroscience (220)
NextGen: Class of 2025 (791)
Non-profit (578)
Northern California (238)
Now hiring (11)
Obesity (18)
Opinion (14)
Ovarian cancer (4)
Pain (5)
Pancreatic cancer (8)
Parkinson's disease (14)
Partnered (4)
Patents (18)
Patient recruitment (5)
Peanut (9)
People (9291)
Pharmaceutical (6)
Phase I (2036)
Phase II (2659)
Phase III (2684)
Pipeline (133)
Policy (3)
Postmarket research (392)
Preclinical (1184)
Press Release (18)
Prostate cancer (20)
Psychedelics (2)
Radiopharmaceuticals (29)
Rare diseases (30)
Real estate (1965)
Recruiting (4)
Regulatory (3735)
Reports (7)
Research institute (631)
Resumes & cover letters (19)
RSV (3)
Series A (10)
Series B (7)
Sickle cell disease (5)
Southern California (247)
Spinal muscular atrophy (34)
Sponsored (6)
Startups (601)
State (1)
Stomach cancer (2)
Supply chain (9)
Tariffs (1)
The Weekly (1)
United States (2600)
Vaccines (49)
Venture capitalists (1)
Weight loss (11)
Women's health (3)
Date
Today (4)
Last 7 days (50)
Last 30 days (266)
Last 365 days (4005)
2025 (983)
2024 (4373)
2023 (5218)
2022 (8519)
2021 (8913)
2020 (8710)
2019 (6069)
2018 (4717)
2017 (5134)
2016 (5242)
2015 (5784)
2014 (4661)
2013 (4139)
2012 (4391)
2011 (4464)
2010 (3986)
Location
Africa (124)
Alabama (10)
Alaska (1)
Arizona (33)
Arkansas (2)
Asia (6296)
Australia (1063)
California (600)
Canada (240)
China (28)
Colorado (34)
Connecticut (29)
Delaware (25)
Europe (13772)
Florida (83)
Georgia (10)
Idaho (5)
Illinois (38)
India (3)
Indiana (37)
Iowa (2)
Japan (18)
Kansas (21)
Kentucky (4)
Louisiana (1)
Maine (24)
Maryland (102)
Massachusetts (382)
Michigan (57)
Minnesota (31)
Missouri (33)
Montana (9)
Nebraska (3)
Nevada (3)
New Hampshire (7)
New Jersey (267)
New Mexico (8)
New York (199)
North Carolina (143)
North Dakota (1)
Northern California (238)
Ohio (37)
Oklahoma (3)
Oregon (3)
Pennsylvania (109)
Rhode Island (10)
South America (176)
South Carolina (3)
Southern California (247)
Tennessee (17)
Texas (155)
Utah (40)
Virginia (11)
Washington D.C. (4)
Washington State (81)
Wisconsin (9)
102,018 Results for "biolytical laboratories".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
bioLytical Laboratories Inc. Announces Launch of its INSTI® HCV Antibody Test for Professional Use in Australia
bioLytical Laboratories Inc., a global leader in rapid diagnostic tests, proudly announces the immediate availability of its INSTI® HCV Antibody Test in the Australian market.
May 19, 2024
·
4 min read
Biotech Bay
bioLytical Donates 1200 HIV Testing Kits Across the United States to Support National HIV Testing Day
bioLytical Laboratories Inc. proudly announces its donation of 1,200 INSTI® HIV-1/2 Antibody Tests to KFF’s Greater Than AIDS campaign in support of National HIV Testing Day, June 27.
June 27, 2024
·
3 min read
Press Releases
HIV and Syphilis Testing Just Got Faster: bioLytical Launches the 1-Minute INSTI® Multiplex HIV-1/2 Syphilis Antibody Test in Australia
March 19, 2025
·
5 min read
bioLytical Laboratories Inc. Donates Tests to Help Boost International Testing Access Ahead of International Testing Week
bioLytical Laboratories Inc., a global leader in rapid in-vitro medical diagnostics and partner Coalition PLUS, a global NGO, announced that together, they have donated and distributed over 8,000 tests across 25 countries to help boost testing access worldwide.
November 22, 2023
·
4 min read
bioLytical Laboratories Inc. Receives Health Canada Authorization for its INSTI® Multiplex HIV-1/2 Syphilis Antibody Test
bioLytical Laboratories Inc., a global leader in rapid in-vitro medical diagnostics, announced that it has received Health Canada authorization for its INSTI® Multiplex HIV-1/2 Syphilis Antibody Test, allowing its immediate entry into the Canadian market.
March 27, 2023
·
6 min read
bioLytical Laboratories Inc. receives WHO PQ for its iStatis COVID-19 Antigen Home Test
bioLytical Laboratories Inc., a global leader in rapid in-vitro medical diagnostics, announced it has received its WHO PQ for its self-test, the iStatis COVID-19 Antigen Home Test, allowing its immediate entry into international markets.
October 18, 2022
·
4 min read
bioLytical Laboratories Inc. Receives its CE Mark for the iStatis COVID-19 Antigen Home Test
bioLytical Laboratories Inc. announced that it is launching a new platform, iStatis, and has received its CE Mark for immediate market entry into Europe for its iStatis COVID-19 Antigen Home Test.
March 21, 2022
·
4 min read
Policy
bioLytical Laboratories Inc. Receives Health Canada Authorization for the iStatis COVID-19 Antigen Home Test
bioLytical Laboratories Inc. announced that it is launching a second test on its new platform, iStatis, after receiving Health Canada authorization for the iStatis COVID-19 Antigen Home Test for its immediate market entry into Canada.
April 1, 2022
·
4 min read
bioLytical Laboratories Inc. Receives Health Canada Authorization for its iStatis COVID-19 Antigen Test
bioLytical Laboratories Inc., a global leader in rapid in-vitro medical diagnostics, announced that it is launching a new testing platform, iStatis, which has received Health Canada authorization for its iStatis COVID-19 Antigen Test, allowing its immediate entry into the Canadian market.
March 7, 2022
·
4 min read
Press Releases
Charles River Laboratories to Present at Barclays Global Healthcare Conference
March 11, 2025
·
1 min read
1 of 10,202
Next
